29 ONDANSETRON (Zofran)
 ACTION
:  Anti
-E
metic
  Selective antagonism of the serotonin 5
-HT3 receptor
 resulting in decreased nausea and 
vomiting
  INDICATIONS
: 
 Severe Nausea and Vomiting
  CONTRAINDICATIONS:
  History of 
hypersensitivity to similar drugs
: Dolasetron (Anzemet), Granisetron (Kytril), or 
Palonosetron (Aloxi)
 or to ondansetron (Zofran)
. 
 Taking Apomorphine (Apokyn, Ixense, Spontane, Uprima
), 
an injectable drug for Parkinson™s 
Disease, or rarely used for erectil
e dysfunction
. 
 Do not give oral tablet or solution to known 
phenylketonurics (contains phenylalanine)
. 
 POTENTIAL SIDE EFFECTS
  Hypotension
  Syncope
  QT prolongation
  Headache
  Diarrhea
  Dizziness
  Anaphylaxis
  Flushing
  Rash
   
ADULT DOSE/ROUTE
: 
 4 mg slow 
IVP
/IM or 8mg tablet 
ODT (
dissolved on the tongue
).   May repeat in 
20min for continued nausea up to 12 mg.
  
PEDIATRIC DOSE/ROUTE:
  Less than 6 months: 
DON™T USE
  6 months 
Œ 
12 years old or <40kg:
 0.1mg/kg slow 
IVP
/IO (max 4mg)
  Greater than 12 
years or >40kg:
 4mg slow 
IVP
/IO
. May 
repeat
 in 
20min for continued 
nausea up to 12mg.
  
NOTES
: 
 Should
 be administered IV over 2
-5 minutes. Rapid administration has been associated 
with increased incidence of side effects 
including
 syncope.
  Oral disintegrating tablets (ODT™s) can be placed on tongue and do not need to be 
chewed. Medication will dissolve and
 be swallowed with saliva.
  Ondansetron can be used in pregnancy and breast
-feeding mothers (pregnancy class B)
. 
  Effective: 11/01/17
 Supersedes: 
03/01/15
   